TTM
−$13.34M
YoY change
-106.5%
5Y CAGR
—
Peak year (2023)
$15.07M
Cumulative EBITDA
−$34.23M
EBITDA history chart for Aehr Test Systems (AEHR) from 1997 to 2025
Latest: −$903.00K
EBITDA growth chart for Aehr Test Systems (AEHR) from 1997 to 2025
Latest: -106.5%
EBITDA history table for Aehr Test Systems (AEHR) from 1997 to 2025
| 2025 | −$903.00K | -106.5% | −$14.72M | ||
| 2024 | $13.82M | -8.3% | −$1.25M | ||
| 2023 | $15.07M | +53.0% | +$5.22M | ||
| 2022 | $9.85M | -632.9% | +$11.70M | ||
| 2021 | −$1.85M | -22.4% | +$534.00K | ||
| 2020 | −$2.38M | -47.4% | +$2.14M | ||
| 2019 | −$4.53M | -456.0% | −$5.80M | ||
| 2018 | $1.27M | -127.2% | +$5.95M | ||
| 2017 | −$4.68M | -21.6% | +$1.29M | ||
| 2016 | −$5.97M | -6.0% | +$381.00K | ||
| 2015 | −$6.35M | -1205.9% | −$6.92M | ||
| 2014 | $574.00K | -119.0% | +$3.59M | ||
| 2013 | −$3.02M | +3.7% | −$109.00K | ||
| 2012 | −$2.91M | +2.1% | −$60.00K | ||
| 2011 | −$2.85M | -4170.1% | −$2.92M | ||
| 2010 | $70.00K | -100.3% | +$24.48M | ||
| 2009 | −$24.41M | -478.8% | −$30.86M | ||
| 2008 | $6.45M | +128.1% | +$3.62M | ||
| 2007 | $2.83M | +150.3% | +$1.70M | ||
| 2006 | $1.13M | -125.6% | +$5.54M | ||
| 2005 | −$4.41M | +6.9% | −$286.00K | ||
| 2004 | −$4.13M | -0.4% | +$17.00K | ||
| 2003 | −$4.14M | +7.8% | −$301.00K | ||
| 2002 | −$3.84M | -280.9% | −$5.96M | ||
| 2001 | $2.12M | -147.3% | +$6.61M | ||
| 2000 | −$4.49M | +7.4% | −$311.00K | ||
| 1999 | −$4.18M | -189.3% | −$8.86M | ||
| 1998 | $4.68M | +8.4% | +$361.00K | ||
| 1997 | $4.32M | — | — |
- 2025−$903.00K-106.5%
- 2024$13.82M-8.3%
- 2023$15.07M+53.0%
- 2022$9.85M-632.9%
- 2021−$1.85M-22.4%
- 2020−$2.38M-47.4%
- 2019−$4.53M-456.0%
- 2018$1.27M-127.2%
- 2017−$4.68M-21.6%
- 2016−$5.97M-6.0%
- 2015−$6.35M-1205.9%
- 2014$574.00K-119.0%
- 2013−$3.02M+3.7%
- 2012−$2.91M+2.1%
- 2011−$2.85M-4170.1%
- 2010$70.00K-100.3%
- 2009−$24.41M-478.8%
- 2008$6.45M+128.1%
- 2007$2.83M+150.3%
- 2006$1.13M-125.6%
- 2005−$4.41M+6.9%
- 2004−$4.13M-0.4%
- 2003−$4.14M+7.8%
- 2002−$3.84M-280.9%
- 2001$2.12M-147.3%
- 2000−$4.49M+7.4%
- 1999−$4.18M-189.3%
- 1998$4.68M+8.4%
- 1997$4.32M—
EBITDA values are taken from Aehr Test Systems's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Aehr Test Systems (AEHR)
According to Aehr Test Systems's latest reported financial statements, the company's current EBITDA (TTM) is −$13.34M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Aehr Test Systems (AEHR) EBITDA is −$903.00K – plunged 106.5% year-over-year.
Aehr Test Systems EBITDA plunged from $15.07M in 2023 to −$903.00K in 2025, a 106.0% drawdown.
Across the available history, EBITDA reached its high of $15.07M in 2023 and its low of −$24.41M in 2009.
Aehr Test Systems EBITDA by Year
Aehr Test Systems EBITDA 2025: −$903.00K
Aehr Test Systems posted EBITDA of −$903.00K in 2025, plunged 106.5% below 2024.
Aehr Test Systems EBITDA 2024: $13.82M
In 2024, Aehr Test Systems reported EBITDA of $13.82M, declined 8.3% below 2023.
Aehr Test Systems EBITDA 2023: $15.07M
Aehr Test Systems EBITDA in 2023 was $15.07M, surged 53.0% from 2022. This figure represents the highest annual value in the available history.
Aehr Test Systems EBITDA 2022: $9.85M
2022's EBITDA for Aehr Test Systems came in at $9.85M, plunged 632.9% below 2021.
Aehr Test Systems EBITDA 2021: −$1.85M
Aehr Test Systems EBITDA in 2021 was −$1.85M.
See more financial history for Aehr Test Systems (AEHR).
Sector peers by EBITDA
Technology peers of Aehr Test Systems (AEHR), ranked by their latest EBITDA
| $160.16B | |
| $144.55B | |
| $144.43B | |
| $88.75B | |
| $34.71B | |
| $18.49B | |
| $14.61B | |
| $7.28B |
- $160.16B
- $144.55B
- $144.43B
- $88.75B
- $34.71B
- $18.49B
- $14.61B
- $7.28B
Frequently asked questions
Aehr Test Systems (AEHR) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation